A patient who had been blind for three years due to ischemic optic neuropathy has partially recovered his vision thanks to the implantation of a microelectrode array in his visual cortex.

The patient, who lost his sight due to an injury to the optic nerve caused by a “bilateral non-arteritic anterior ischemic optic neuropathy”, has partially recovered his vision.

The breakthrough, published in Brain Communications, opens new therapeutic possibilities in the field of neurotechnology, while also raising important ethical questions about the limits and uses of brain stimulation.

The lead author of the study is Eduardo Fernández Jover, director of the Institute of Bioengineering of the Miguel Hernández University of Elche (UMH) and head of the Bioengineering, Biomaterials and Nanomedicine area of ​​CIBER (CIBER BBN).

In 2022, the patient volunteered to participate in an experimental clinical trial at UMH, in which he had an implant placed in his brain to stimulate the cortex, which would allow him to reproduce visual perceptions.

The procedure involved implanting an array of 100 microelectrodes in the patient’s primary visual cortex. The researchers then electrically stimulated the brain to produce artificial visual perceptions.

After a series of tests, the doctors confirmed that the patient had recovered some of his vision.

The case has surprised researchers because the patient had been blind for three years and has continued to retain some visual function after the brain implant was removed three years ago. Other cases of vision recovery involved patients with recent optic nerve damage.

The recovery of his vision allowed him to perceive light, detect movement, and even read large characters.

For six months, he and the other participants in the trial trained the system and established thresholds. The training consisted of tasks to assess light, spatial localization, movement, visual acuity, and contrast sensitivity.

Given that visual improvement only occurred in one of the four participants in the clinical trial, future studies will determine whether it is an isolated case or if it could occur again in other patients.

Previously, in 2021, the Biomedical Engineering laboratory at UMH had already implanted a brain chip in a blind patient, enabling him to perceive letters and shapes of objects.

Background

As we have previously reported, other brain implant interventions have offered promising results so far.

There are numerous experiences with a brain-computer interface (BCI) such as the Neuralink brain chip, or in China the Beinao No. 1 chip implanted in three human patients.

In addition to achieving the recovery of bilingual communicative ability in a patient after a stroke or the possibility for ALS patients to communicate again with their environment.

Advances in the fields of neuroscience and computing offer therapeutic hopes, but also bioethical dilemmas.

Bioethical assessment

The use of brain stimulation, whether invasive (via microchips) or non-invasive (via electrostimulation), is a promising option in the recovery of patients after strokes or pathologies that severely affect their ability to communicate, move, or perceive the environment, as well as other cognitive processes.

The application of these advances to therapeutics is commendable, ethically acceptable, and should be promoted to make them accessible to all patients who need them. However, their high cost may pose a significant barrier given the current state of research.

But alongside this indication, other enhancements can be proposed, which do not seek to restore lost functions but rather to implement new capabilities. These include improving sensory perception, memory, or other brain functions that confer an advantage over natural human abilities.

The possibility of inducing moods through these procedures, or altering individuals’ perceptions or behavior, presents high-risk scenarios that could constitute a violation of human dignity, freedom, and free will. This could contribute to the subjugation of some, the weakest, by others, the “enhanced.”

As always, bioethics must accompany the new possibilities that scientific advances in neuroscience offer in understanding the human brain. Neuroethics is therefore an essential discipline today, ensuring that these new possibilities in the field contribute to progress rather than becoming a threat to it.

Julio Tudela and Ester Bosch

Bioethics Observatory – Institute of Life Sciences

Catholic University of Valencia

Share This Story, Choose Your Platform!